Apollomics (APLM) Treasury Shares (2020 - 2023)
Apollomics (APLM) posted quarterly Treasury Shares of $68000.0 for Q4 2023, up 200.0% year-over-year from $22666.7 in Q4 2022, and up 200.0% quarter-over-quarter from -$68000.0 in Q4 2022.
Apollomics (APLM) Treasury Shares (2020 - 2023) Analysis & Trends
Apollomics (APLM) has reported Treasury Shares for 4 consecutive years, with $68000.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Treasury Shares rose 200.0% year-over-year to $68000.0; the TTM figure through Dec 2023 stood at $68000.0 (up 200.0% YoY), while the FY2023 annual figure was $68000.0, up 200.0% from the prior year.
- Treasury Shares improved to $68000.0 in Q4 2023 per APLM's latest filing, from -$68000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $26.4 million in Q4 2020 and bottomed at $4967.0 in Q4 2022.
- Historically, Treasury Shares has averaged $6.8 million across 3 years, with a median of $318809.5 in 2021.
- Annual changes were most pronounced in 2022 — Treasury Shares slumped 104.13% — and 2023, when it jumped 200.0%.
- Apollomics' Treasury Shares stood at $3.3 million in 2020, then plunged by 49.35% to $1.6 million in 2021, then sank by 104.13% to -$68000.0 in 2022, then surged by 200.0% to $68000.0 in 2023.
- Business Quant data shows APLM's Treasury Shares at $68000.0 in Q4 2023, -$68000.0 in Q4 2022, and $68000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Apollomics | 35.18 Mn | 31.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2023 | 68,000.00 |
| Dec 31, 2022 | 4,967.00 |
| Dec 31, 2022 | -68,000.00 |
| Dec 31, 2022 | -68,000.00 |
| Dec 31, 2022 | 4,967.00 |
| Jun 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 68,000.00 |
| Jun 30, 2022 | 496,752.00 |
| Jun 30, 2022 | 496,752.00 |
| Dec 31, 2021 | 140,867.00 |
| Dec 31, 2021 | 1.65 Mn |
| Dec 31, 2021 | 1.65 Mn |
| Dec 31, 2021 | 140,867.00 |
| Dec 31, 2020 | 26.37 Mn |
| Dec 31, 2020 | 26.37 Mn |
| Dec 31, 2020 | 3.25 Mn |
| Dec 31, 2020 | 3.25 Mn |